What are the Steps of Clinical Audit

Standard Operating Procedure: Clinical Audit Lifecycle Management

1. Document Control Block

• Document ID: SOP-TR-CLIN-042
• Effective Date: October 24, 2023
• Version: 3.2.0
• Review Cadence: Annual
• Owner: Office of the Chief Architect & Director of Clinical Governance

---

2. Executive Summary & Purpose

This Standard Operating Procedure (SOP) defines the institutional requirements for executing a systematic clinical audit within Template Registry facilities and partnered networks. The purpose of this protocol is to measure clinical practice against explicit, evidence-based standards, identify systemic variances, execute targeted remediation cycles, and enforce continuous quality improvement (CQI) to ensure patient safety and regulatory compliance.

---

3. Scope & Prerequisites

• Scope: Applies to all clinical personnel, quality assurance officers, data stewards, and administrative leads across all operational units.
• Required Tools & Software:
  • Enterprise Electronic Health Record (EHR) auditing module
  • Template Registry Secure Data Vault (TR-SDV v4.1)
  • Statistical analysis suite (RStudio / SPSS)
  • Institutional Review Board (IRB) exemption or approval documentation
• PPE Requirements: Standard administrative attire; specialized sterile PPE only required when physical chart audits occur inside high-containment clinical environments.

---

4. Roles & Responsibilities (RACI Matrix)

---

5. Step-by-Step Procedure

Phase 1: Topic Selection and Standard Definition

• Identify clinical areas experiencing high variability, adverse outcomes, or regulatory scrutiny.
• Establish explicit, measurable criteria based on national guidelines (e.g., NICE, WHO) or institutional benchmarks.
• Define the target sample size using a statistically valid power calculation ($\alpha = 0.05, \text{Power} = 0.80$).

Phase 2: Data Collection and Extraction

• Secure institutional approval and data-sharing agreements via the TR-SDV governance portal.
• Extract retrospective or prospective patient data utilizing standardized EHR query templates.
• Anonymize all datasets in compliance with HIPAA/GDPR regulations prior to analysis.
• Input structured data points into the audit matrix checklist.

Phase 3: Data Analysis and Variance Identification

• Compute adherence percentages for each clinical standard ($(\text{Compliant Episodes} / \text{Total Eligible Episodes}) \times 100$).
• Perform root-cause analysis (RCA) using Ishikawa (Fishbone) diagrams for any standard falling below the 90% threshold.
• Document systemic bottlenecks, software limitations, or knowledge gaps contributing to variance.

Phase 4: Reporting and Action Plan Formulation

• Draft the comprehensive Clinical Audit Report utilizing Template Registry institutional formatting.
• Convene a multidisciplinary stakeholder review meeting to present findings.
• Formulate a SMART (Specific, Measurable, Achievable, Relevant, Time-bound) Action Plan.
• Assign explicit remediation owners for each identified deficiency.

Phase 5: Re-Audit and Continuous Monitoring

• Implement local operational changes, workflow updates, or mandatory staff retraining.
• Schedule the secondary re-audit cycle within 90 to 180 days post-intervention.
• Compare re-audit metrics against baseline data to verify closure of the audit loop.
• Archive final documentation in the Template Registry Compliance Repository.

---

6. Quality Assurance & Pro-Tips

Best Practices

• Standardized Nomenclature: Ensure all data extractors utilize identical definitions for numerator and denominator parameters to avoid skewing longitudinal data.
• Clinician Engagement: Involve frontline clinical staff early in Phase 1; audits designed in isolation face high resistance during the remediation phase.

Common Pitfalls

• The "Audit Loop" Failure: Collecting data and publishing reports without executing Phase 5 (re-audit). An unclosed loop invalidates the quality improvement lifecycle.
• Sampling Bias: Cherry-picking patient charts to artificially inflate compliance scores. Always utilize randomized programmatic sampling.

Metric Thresholds

• Green (Optimal): $\ge 95%$ adherence to clinical standard.
• Amber (Action Required): $85% - 94.9%$ adherence; mandatory localized review.
• Red (Critical Failure): $< 85%$ adherence; immediate escalation to Clinical Governance Lead and mandatory system-wide intervention.

---

7. Frequently Asked Questions

Q1: What differentiates a clinical audit from clinical research?

A: Clinical research determines what the best clinical practice is (generating new knowledge), whereas a clinical audit measures whether current practice conforms to established, evidence-based standards. Audits require operational governance approval rather than full formal clinical trial IRB oversight, provided patient data remains anonymized and internal.

Q2: How should we handle missing documentation during chart extraction?

A: Missing documentation must be logged explicitly as "Non-Compliant" for the specific standard being evaluated. Do not infer clinical intent or assume unrecorded actions occurred; if it is not documented in the EHR, it did not happen within the scope of the audit.